Related content

Treatment-of-choice for Buerger’s disease (thromboangiitis obliterans): still an unresolved issue

By Paraskevas Kosmas  

Clinical Rheumatology, Vol. 27, Iss. 4, 2008-04 ,pp. : 547-547

Springer Publishing Company

Access to resources Recommend Favorite

The development of systemic sclerosis classification criteria

By Walker Jennifer   Pope Janet   Baron Murray   LeClercq Sharon   Hudson Marie   Taillefer Suzanne   Edworthy Steven   Nadashkevich Oleg   Fritzler Marvin  

Clinical Rheumatology, Vol. 26, Iss. 9, 2007-09 ,pp. : 1401-1409

Springer Publishing Company

Access to resources Recommend Favorite

Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis

By Kishida Dai  

Modern Rheumatology, Vol. 21, Iss. 2, 2011-04 ,pp. : 215-218

Springer Publishing Company

Access to resources Recommend Favorite

Acute hepatitis in adult Still’s disease during corticosteroid treatment successfully treated with anakinra

By Mylona Eleni   Golfinopoulou Styliani   Samarkos Michael   Fanourgiakis Panagiotis   Papadakos Vasilios   Skoutelis Athanasios  

Clinical Rheumatology, Vol. 27, Iss. 5, 2008-05 ,pp. : 659-661

Springer Publishing Company

Access to resources Recommend Favorite

Successful treatment of refractory adult-onset Still’s disease with infliximab. A prospective, non-comparative series of four patients

By Kokkinos Alexander   Iliopoulos Alexios   Greka Paraskevi   Efthymiou Anna   Katsilambros Nicholas   Sfikakis Petros  

Clinical Rheumatology, Vol. 23, Iss. 1, 2004-02 ,pp. : 45-49

Springer Publishing Company

Access to resources Recommend Favorite